Exelixis Inc (NAS:EXEL)
$ 20.91 -0.32 (-1.51%) Market Cap: 6.09 Bil Enterprise Value: 5.42 Bil PE Ratio: 32.52 PB Ratio: 2.90 GF Score: 92/100

Q4 2020 Exelixis Inc Earnings Call Transcript

Feb 10, 2021 / 10:00PM GMT
Release Date Price: $23.03 (+0.35%)
Operator

Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Full Year 2020 Financial Results Conference Call. My name is Latif, and I will be your operator for today. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host for today, Ms. Susan Hubbard, Executive Vice President of Public affairs and Investor Relations. Please proceed.

Susan T. Hubbard
Exelixis, Inc. - EVP of Public Affairs & IR

Thank you, Latif, and thank you all for joining us for the Exelixis Fourth Quarter and Full Year 2020 Financial Results Conference Call. Joining me on today's call are Mike Morrissey, our President and CEO; Chris Senner, our Chief Financial Officer; Gisela Schwab, our Chief Medical Officer; and P.J. Haley, our Executive Vice President of Commercial, who will together review our corporate, financial, development and commercial progress for the fourth quarter 2020 ended December 31, 2020. Peter Lamb, our Chief Scientific Officer, is also here and will join us for the question-and-answer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot